1/31/2023 6:46:52 AM
Pfizer Q4 Reported EPS $0.87; Adj EPS $1.14
1/6/2023 6:49:44 AM
Pfizer : FDA Accepts For Priority Review SBLA For 20-Valent Pneumococcal Conjugate Vaccine
12/29/2022 6:49:57 AM
Pfizer Announces Positive Top-line Results From Phase 3 BENEGENE-2 Study Of Hemophilia B Gene Therapy Candidate
12/21/2022 6:48:47 AM
Pfizer Says FDA And EMA Accepted Etrasimod Regulatory Submissions For Ulcerative Colitis
12/14/2022 1:06:06 AM
Roche Collaborates With Pfizer To Educate On Importance Of COVID-19 Testing
12/10/2022 1:43:22 PM
Pfizer Presents Updated Favorable Elranatamab Data From Pivotal Phase 2 MagnetisMM-3 Trial
12/9/2022 11:45:44 AM
Pfizer Declares Q1 Dividend Of $0.41/share, Payable March 3/ Record Jan. 27
12/9/2022 11:25:55 AM
Pfizer Inc. (PFE) Declares $ 0.41 Dividend for Q1 23, Record Date 1/27/2023